Avalon Technologies Limited (AVALON)
Please find the enclosed Earnings Call Transcript for the Quarter Ended June 30, 2026.
AI summary
- Q1 FY27 revenue Rs. 484 Cr +50% y-y; EBITDA margin 12.0%, PAT Rs. 35 Cr (7.2% margin)
- FY27 revenue growth guidance raised to 26-30% from 24-27%
- Order book Rs. 2,208 Cr, +23.4% y-y, average execution 14 months
- India manufacturing EBITDA margin 16.7%, US losses narrowed to Rs. 4 Cr PAT
- Box-build contribution increased to 59.9% in Q1 FY27
- Capex Rs. 16 Cr in Q1; new Chennai plant to start Q2 FY27
- Multiple analyst queries on margin trajectory; mgmt maintains 33-35% gross margin range
- Growth engines: existing business, new programs, expanding pipeline gaining momentum
- Focus on leadership, process automation, AI capabilities for next phase growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 AVALON — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add AVALON to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Avalon Technologies Limited
Important.
The summary above is generated automatically from Avalon Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.